Amirhossein Sahebkar

Amirhossein Sahebkar
امیرحسین صاحبکار
EducationMashhad University of Medical Sciences (PharmD, PhD)
Scientific career
FieldsMedical biotechnology, cardiovascular disease
InstitutionsMashhad University of Medical Sciences

Amirhossein Sahebkar is an Iranian biotechnologist specializing in cardiovascular diseases. He is a faculty member in the department of medical biotechnology at the Mashhad University of Medical Sciences.

Life

Sahebkar completed a Pharm.D. in 2008 from Mashhad University of Medical Sciences.[1] His dissertation was titled, An investigation of serum antibody titres to heat shock protein 27 (anti- Hsp27) as a biomarker for the detection of acute coronary syndrome.[1] Sahebkar earned a Ph.D. in pharmaceutical biotechnology from the Mashhad University of Medical Sciences. His dissertation was titled, Preparation and evaluation of nanoliposomes conjugated with apolipoprotein B-100 antibodies as a therapeutic option for serum LDL reduction.[1] He completed a postdoctoral fellowship in cardiometabolic diseases at the University of Western Australia.[2]

Sahebkar is a faculty member in the department of medical biotechnology at the Mashhad University of Medical Sciences.[3] His research focuses on cardiovascular disease, atherosclerosis, and blood lipids.[3] He is a member of the Iran's National Elites Foundation.[1] In 2016, he was presented the Professor Dr. Fereydoun Azizi award by the Iranian Academy of Medical Sciences.[3][2]

References

  1. ^ a b c d Sahebkar, Amirhossein. "Resume". USERN. Retrieved 2024-02-17.
  2. ^ a b "دانشمند برگزیده دهه اخیر کشور در علوم‌پزشکی کیست؟". www.khabaronline.ir (in Persian). 2018-02-02. Retrieved 2024-02-17.
  3. ^ a b c "انتخاب دکتر صاحبکار بعنوان دانشمند برگزیده دهه اخیر در حوزه علوم پزشکی". ایسنا (in Persian). 2018-02-02. Retrieved 2024-02-17.
Stub icon 1 Stub icon 2

This Iranian academic-related biographical article is a stub. You can help Wikipedia by expanding it.